Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Arecor and GSK join forces to develop new vaccine formulations

June 16, 2011

JDFR and Selecta Biosciences collaborate on vaccines for type 1 diabetes

June 15, 2011

Adolor enters agreement to reacquire full rights to alvimopan hydrate from GSK

June 15, 2011

Vertex and Alios BioPharma enter into agreement for nucleotide drug candidates

June 15, 2011

New company BliNK Therapeutics to develop monoclonal antibodies

June 15, 2011

Synthes and Eli Lilly sign agreement focused on osteoporosis and bone fractures

June 14, 2011

Bionomics and Merck Serono extend MS collaboration

June 14, 2011

Avila Therapeutics and NIAID enter agreement for preclinical evaluation of AVL-192

June 10, 2011

Merck Serono and Affectis sign agreement to develop oral P2X7 receptor antagonists

June 10, 2011

Seattle Genetics exercises option to codevelop second antibody-drug conjugate with Agensys

June 10, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...